Impaired Renal Function Clinical Trial
— Ordoclic-IROfficial title:
Impact of a Counselling System Coupled With a Computer Prescribing System to Optimize the Use of the Drugs for Old Subjects Having Renal Function Impairment
Verified date | October 2008 |
Source | Assistance Publique - Hôpitaux de Paris |
Contact | n/a |
Is FDA regulated | No |
Health authority | France: Ministry of Health |
Study type | Observational |
To evaluate the quality of orders for target drugs in old patients with impaired renal function, hospitalized or living in long stay units, and to improve these practices by means of a counselling system coupled to a computer prescribing system
Status | Completed |
Enrollment | 12 |
Est. completion date | December 2008 |
Est. primary completion date | December 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - geriatrics hospital units or nursing homes - using the same electronic prescribing system called ORDOCLIC - agreeing to participate in the study Exclusion Criteria: |
Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
France | hopital Charles Foix et Université Paris 6 | Ivry-sur-Seine |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of the changes from baseline of proportions [patients with inappropriate target drug prescribing/patients with creatinine clearance<60 ml/mn] between control and intervention groups | 6 months | No | |
Secondary | Time-related improvement of target drug prescribing in intervention units | 9 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04252430 -
RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects
|
Phase 1 | |
Completed |
NCT01716455 -
Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function
|
Phase 1 | |
Completed |
NCT02431481 -
Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011
|
Phase 1 | |
Completed |
NCT02087566 -
Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)
|
N/A | |
Completed |
NCT04179630 -
Study of Aldafermin (NGM282) in Participants With Impaired Renal Function
|
Phase 1 | |
Completed |
NCT00779922 -
Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function
|
Phase 2 | |
Completed |
NCT01507350 -
Effects of Obesity Surgery on Renal Function
|
||
Active, not recruiting |
NCT01760031 -
Longterm Follow-up After Remote Ischemic Preconditioning for Prevention of Contrast-induced Nephropathy
|
N/A | |
Completed |
NCT03776539 -
A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02
|
Phase 1 | |
Completed |
NCT01035320 -
Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment
|
Phase 4 | |
Completed |
NCT00604357 -
CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment
|
Phase 3 | |
Completed |
NCT02965040 -
A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function
|
Phase 1 | |
Completed |
NCT00981045 -
Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function
|
Phase 3 | |
Completed |
NCT02467478 -
Linagliptin's Effect on CD34+ Stem Cells
|
Phase 4 | |
Recruiting |
NCT04620590 -
An Open Label Phase IV Study to Evaluate Dapagliflozin Treatment in Type 2 Diabetes Mellitus Patients With Impaired Renal Function
|
Phase 4 |